Novo Nordisk Pharma Taiwan awarded ESG Program of the Year - Taiwan by the Healthcare Asia Pharma Awards

The company's Corporate Social Responsibility awareness programme aims to give back to local communities and take action for environmental improvement.

With the world experiencing various challenges by the day, long-term commitment is now necessary instead of simple day-long ESG programmes. Novo Nordisk Pharma Taiwan understood this need and, with its Corporate Social Responsibility (CSR) initiative, is awarded the ESG Program of the Year - Taiwan at the Healthcare Asia Pharma Awards 2023.

The awards programme recognises commendable performances or cutting-edge developments from healthcare organisations across Asia. As the award winner, Novo Nordisk Pharma Taiwan was distinguished for its commitment to making a better tomorrow for the local community and the environment.

The Triple Bottom Line (TBL) principle is anchored in the company’s Articles of Association and the Novo Nordisk Way (NN Way). It is applied to ensure that business decisions balance financial, social and environmental considerations, always keeping in mind the best interests of the patients and communities we serve.

The Novo Nordisk Taiwan: Corporate Social Responsibility Day ESG Programme, which aligns with the TBL principle and several UN Sustainable Development Goals, was launched in 2021 and features a series of awareness campaigns which imprint and remind Corporate Social Responsibility in stakeholders' daily practice, as well as connecting it with the company's business purpose, to drive change to defeat diabetes and other serious chronic diseases such as obesity, a rare blood and rare endocrine diseases.

It takes more than medicine to defeat a serious chronic disease. Together with partnerships, Novo Nordisk Pharma Taiwan planned the ESG programme to promote a healthy lifestyle to prevent obesity and diabetes, ensure that children grow up healthily and halt the steep rise in obesity.

In 2021, Novo Nordisk Pharma Taiwan collaborated with Green Hope Springs (GHS) Social Enterprise and Yilan County government for the first-ever Yilan Football Cup to support children and communities in Eastern rural areas. Meanwhile, in 2022, Novo Nordisk Pharma Taiwan sought to raise environmental appreciation through an on-site marine educational session for those within the organisation.

Novo Nordisk Pharma Taiwan also seeks to build interest in the traditional fishing technique of Khan-koo of the Northern Coast area of Taiwan. The company has been showcasing this cultural heritage skill through the experience of the next generation and via multi-communication channels to raise public awareness and interest.

Amongst the achievements of Novo Nordisk Pharma Taiwan, it made a significant environmental impact on carbon sequestration of 165kg, carbon dioxide absorption of 571kg, reduce soil loss of 11405kg, reduces carbon emission of 3872kg, and oxygen production of 300013 litres annually.

Novo Nordisk Pharma Taiwan has been awarded the Best Foreign Company in the Golden Merchant Award and was the winner of the Better Business Award in the CSR category for its outstanding performance in financial, environmental, and social aspects — an official recognition for the company's Triple Bottom Line achievement.

Novo Nordisk has been driving change for better health since 1923, 2023 marks the 100^th anniversary of the company. As we turn 100, we renew our commitment to drive change for a healthy world today and for generations to come. We are tackling our waste and reducing emissions to achieve net zero CO₂ emissions by 2045 at the latest; we are working to improve access to healthcare in every country we operate, and we are at the frontline in creating the healthy communities of tomorrow.